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Simple and Efficient Analysis of Disease Association
with Missing Genotype Data
D.Y. Lin,1,* Y. Hu,1 and B.E. Huang1
Missing genotype data arise in association studies when the single-nucleotide polymorphisms (SNPs) on the genotying platform are not
assayed successfully, when the SNPs of interest are not on the platform, or when total sequence variation is determined only on a small
fraction of individuals. We present a simple and ﬂexible likelihood framework to study SNP-disease associations with such missing
genotype data. Our likelihood makes full use of all available data in case-control studies and reference panels (e.g., the HapMap), and
it properly accounts for the biased nature of the case-control sampling as well as the uncertainty in inferring unknown variants. The
corresponding maximum-likelihood estimators for genetic effects and gene-environment interactions are unbiased and statistically
efﬁcient. We developed fast and stable numerical algorithms to calculate the maximum-likelihood estimators and their variances,
and we implemented these algorithms in a freely available computer program. Simulation studies demonstrated that the new approach
is more powerful than existing methods while providing accurate control of the type I error. An application to a case-control study on
rheumatoid arthritis revealed several loci that deserve further investigations.Introduction
Thanks to comprehensive catalogs of human genetic
variation1,2 and precipitous drops in genotyping costs,
case-control association studies have become the primary
tool in searching for genetic determinants of complex
diseases. There are missing genotype data in all these stud-
ies. Even in a well-designed study with high-quality geno-
typing, some individuals will have missing genotypes at
certain single-nucleotide polymorphism (SNP) sites be-
cause of assay failures. Genotype data may also be missing
by design. For example, it is cheaper to genotype a subset
of study subjects on a high-density platform and the rest
on a low-density platform. Also, it may be economically
feasible to completely sequence a small fraction of individ-
uals, rather than all individuals, in a large study.
There has been an enormous recent interest in untyped
SNPs, i.e., the SNPs that are not even on the genotyping
platform used in the study. This is an extreme form ofmiss-
ing genotype data in which the SNPs of interest aremissing
on all study subjects. Conducting association analysis at
untyped SNPs can facilitate the selection of SNPs to be gen-
otyped in follow-up studies. This kind of analysis is also
highly desirable if we wish to validate the ﬁndings of one
study on some other studies that use different genotyping
chips or to perform meta-analysis by combining data from
association scans that use different SNP sets.
The prevailing approach to dealing with missing
genotype data is imputation,3–6 which predicts themissing
genotypes from the observed genotypes at neighboring
SNPs and then uses the predicted values in downstream
association analysis. This strategy, although very intuitive
and useful, is suboptimal. Imputing missing data for cases
and controls together can lead to a bias toward the null444 The American Journal of Human Genetics 82, 444–452, Februahypothesis of no association and therefore a loss of power,
whereas imputing missing genotypes for cases and con-
trols separately can inﬂate type I error rates.3,7,8
An alternative, less ambitious approach is touse thehaplo-
type frequencies of neighboring SNPs to estimate the allele
frequencies of the untyped SNP.9–11 This strategy is easy to
implement but is restricted to the comparison of allele fre-
quencies between cases and controls. The estimation of the
allele frequencies may be inaccurate, especially for cases,10
so the power of the corresponding association test may be
compromised. In addition, some of the variance estimators
for the estimated allele frequencies require haplotype data.
In this article, we provide a general likelihood-based
framework for handling any form of missing genotype
data. We derive the observed-data likelihood that properly
reﬂects the biased nature of the case-control sampling and
that incorporates appropriate external data, such as the
HapMap data. Themaximization of the observed-data like-
lihood leads to valid and efﬁcient analysis of genetic effects
and gene-environment interactions. We demonstrate
through simulation studies that our approach is more
powerful than the two existing approaches mentioned
above while providing correct control of the type I error.
We illustrate the new method through an application to
a case-control study on rheumatoid arthritis (RA [MIM
180300]). The software implementing the new method
can be downloaded from our lab website.
Material and Methods
We consider a set of M SNPs that are in linkage disequilibrium
(LD). Each SNP is biallelic with allele values 0 and 1. The SNP ge-
notypes may be missing. We use the known genotypes of the
SNPs that are in LD with the SNP with missing genotypes to infer1Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7420, USA
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its unknown values. To this end, we consider the joint distribution
of the M SNPs. Let G denote the multilocus genotype of the
M SNPs and H the corresponding diplotype. Suppose that the
M SNPs have a total of K haplotypes, each of which is a unique
sequence of 0s and 1s. We denote the K haplotypes by h1, $$$,
hK, with frequencies p1, $$$, pK. We write H ¼ (hk, hl) if the diplo-
type consists of haplotypes hk and hl. Note that H¼ (hk, hl) implies
that G ¼ hk þ hl, where the summation is taken component-wise.
Let Y denote the disease status (1 ¼ disease, 0 ¼ no disease). The
effects of SNP genotypes on the risk of disease can be formulated
through the following logistic regression model:
PðY ¼ 1 jH ¼ ðhk,hlÞÞ ¼ e
aþbTZðhk ,hlÞ
1þ eaþbTZðhk ,hlÞ, (1)
where a is an intercept term, b pertains to log-odds ratios, and
Z(hk, hl) is a (possibly vector-valued) genotype score induced by
the diplotype (hk, hl). In this article, all vectors are column vectors,
and aT denotes the transpose of a. If we are interested in the
additive effect of a single SNP, then we set Z(hk, hl) to be the value
of (hkþ hl) at that SNP position; if we are interested in the recessive
effect, then Z(hk, hl) indicates whether the value of (hk þ hl) at the
SNP of interest is equal to 2 or not; dominant and codominant
effects can be similarly modeled. We can deﬁne Z(hk, hl) to formu-
late the joint effects of all M SNPs or any subset of them.
Suppose that we have a case-control study with a total of
n subjects. For i ¼ 1, $$$, n, let Yi and Gi denote the values of
Y and G for the ith subject. The values of Gi may be missing at
any positions. To reﬂect the biased nature of the case-control
sampling, we adopt the retrospective likelihood Pni ¼ 1P(GijYi).
UnderModel 1 with rare disease and Hardy-Weinberg equilibrium,
this likelihood takes the form
LSðqÞ ¼
Yn
i¼1
P
ðhk ,hlÞGi e
Yib
TZðhk ,hlÞpkplP
k,l e
Yib
TZðhk ,hlÞpkpl
, (2)
where q ¼ (bT, pT)T, p ¼ (p1, $$$, pK)T, the summations in both the
numerator and denominator are taken over k ¼ 1, ., K and l ¼
1,., K, and (hk, hl) ~Gimeans that the diplotype (hk, hl) is compat-
ible with the observed value of genotype Gi (i.e., hk þ hl ¼ Gi at all
SNP sites with nomissing values).Wemaximize LS(q) to obtain the
maximum-likelihood estimator (MLE) of q. The maximization can
be carried out through the Newton-Raphson algorithm described
in Appendix A.
The standard approach to the problem of missing genotypes is
to remove the subjects with missing values. This strategy can be
highly inefﬁcient, especially when there is substantial missingness
and different subjects are missing on different SNPs. The proposed
MLE method does not remove any subjects and uses all the avail-
able data to perform efﬁcient analysis.
To reduce cost, wemay purposely set some genotypes tomissing.
In a large study, for instance, it is cost effective to genotype a subset
of individuals with a high-density platform and the rest with a low-
density one. Likewise, itmaybe economically feasible to determine
complete sequencevariation for only a small fractionof individuals
rather than all individuals. TheMLE approach is particularly suited
to such situations, allowing efﬁcient analysis at all the SNPs of the
high-density platform and for complete sequence variation.
If one of theM SNPs is untyped (i.e., not present on the genotyp-
ing platform used for the study) or missing on all study subjects,
then there is no information in the study data to determine the
joint distribution of the M SNPs. We can ascertain the joint distri-
bution from an external reference database, such as the HapMap.1The AmNaturally, the case-control study and the reference panel are as-
sumed to be generated from the same underlying population. We
denote the likelihood forp based on the reference database by LR(p).
To be speciﬁc, we consider the HapMap trio data. Suppose that
we have a total of ~n trios, which is 30 for the Centre d’Etude du
Polymorphisme Humain (CEU) sample. For j ¼ 1,/,~n, the geno-
type data for the jth trio consist of Gj ¼ (GFj, GMj, GCj), where
GFj, GMj, and GCj denote the genotypes for the father, mother,
and child, respectively. In this case,
LRðpÞ ¼
Y~n
j¼1
X
ðhk ,hl ,hk0 ,hl0 ÞGj
pkplpk0 pl0 , (3)
where the summation is takenoverk, l, k0, l0 ¼1,.,K, and (hk,hl,hk0,
hl0)~Gjmeans that (hk, hl) is compatible withGFj, (hk0, hl0) is compat-
ible withGMj, and (hk, hk0), (hk, hl0), (hl, hk0), or (hl, hl0) is compatible
withGCj. The likelihood forunrelated individuals is a special caseof
Equation 3 with missing genotypes for all parents.
The likelihood for q that combines the study data and reference
database is
LCðqÞ ¼ LSðqÞLRðpÞ:
We maximize LC(q) through the Newton-Raphson algorithm de-
scribed in Appendix B. The resulting MLE of q is approximately
unbiased and normally distributed. Furthermore, theMLE is statis-
tically efﬁcient in that it has the smallest variance among all valid
estimators and the corresponding test of association is the most
powerful among all valid tests based on the same data and same
assumptions.
The above framework allows association analysis at all the SNPs
in the reference database. To maximize efﬁciency, we choose a set
of (M  1) SNPs that provides the best prediction of the missing
SNP genotype. The accuracy of prediction is measured by Rs
2 of
Stram12 or equivalently by MD of Nicolae.
13 For any SNP of inter-
est, we ﬁnd the set of (M  1) SNPs within 100 kb, for example,
that yields the largest value of Rs
2. If Rs
2 is close to 1, then the anal-
ysis will be nearly as efﬁcient as if the SNP of interest is measured
on all study subjects.
Performing association tests at untyped SNPs yields awider range
of SNPs to be considered for genotyping in follow-up studies. An-
other application is to validate the ﬁndings of one study on other
studies that use different genotyping chips. Indeed, it is desirable
to combine data across studies so as to increase power to detect
small genetic effects. To perform this kind of meta-analysis, we in-
clude inLS(q) all the subjects fromthe studies of similar populations
and multiply LC(q) over different types of populations.
We can estimate the allele frequencies for any SNPs of interest
by using the MLE of p. To infer missing genotypes, we calculate
the posterior probabilities of individual diplotypes
PfHi ¼ ðhk,hlÞ jGi,Yig ¼ Iððhk,hlÞGiÞe
Yib
TZðhk ,hlÞpkplP
ðhk0 ,hl0 ÞGi e
Yib
TZðh
k
0 ,h
l
0 Þpk0 pl0
,
k,l ¼ 1,.,K; i ¼ 1,.,n,
where I($) is the indicator function and the unknown parameters
b and p are evaluated at their MLEs. By taking appropriate sums of
these posterior probabilities, we can obtain the posterior probabil-
ities for the genotypes of interest.
We can extend our framework to study gene-environment inter-
actions. Let X represent environmental factors. We expand Model
1 as follows:erican Journal of Human Genetics 82, 444–452, February 2008 445
PðY ¼ 1 jH ¼ ðhk,hlÞ,X ¼ xÞ ¼ e
aþbTZðhk ,hl ,xÞ
1þ eaþbTZðhk ,hl ,xÞ,
where Z(hk, hl, x) is a speciﬁc vector function of (hk, hl) and x. The
retrospective likelihood
Qn
i¼1PðGi,XijYiÞ involves the unknown
distribution of X, which is high-dimensional. We use the
proﬁle-likelihood arguments of Lin and Zeng14 to eliminate the
distribution ofX and replace Equation 2 with the following proﬁle
likelihood:
LSðqÞ ¼
Yn
i¼1
P
ðhk ,hlÞGi e
YifmþbTZðhk ,hl ,XiÞgpkplP
k,l,y e
yfmþbTZðhk ,hl ,XiÞgpkpl
, (4)
where q ¼ (m, bT, pT)T, m is an unknown constant, and the summa-
tion in the denominator is taken over k, l ¼ 1,., K and y ¼ 0, 1.
The maximizations of this likelihood and the corresponding com-
bined likelihood LC(q) are discussed in Appendices A and B.
Whereas our approach integrates inference of missing geno-
types and estimation of odds ratios into a single likelihood frame-
work, the imputation approach ﬁrst imputes missing genotypes
(without reference to phenotype information) and then assesses
the association between the imputed genotypes and the pheno-
type. There are various ways to impute missing genotypes.3–6 An
attractive recent method5 generates each individual’s genotype
from a hidden Markov model in which the hidden states are a
sequence of pairs of the haplotypes observed in the reference
panel and in which mutations and recombinations are allowed.
Given the imputed genotypes, one can use the most likely geno-
type, the expected genotype counts, or the probability distribu-
tion of the genotype for each individual in the ensuing association
test. Marchini et al.5 recommended the use of the probability
distribution because it accounts for more of the uncertainty in im-
puted genotypes. Because it disregards phenotype information
when imputing missing genotypes and ignores case-control
sampling in association analysis, the imputation approach may
not provide unbiased estimation of odds ratios at causal SNPs.
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th446 The American Journal of Human Genetics 82, 444–452, FebruaryFigure 1. Type I Error of Association Tests on SNP 61 at the
1% Nominal Significance Level When SNP 60 Has an
Additive Effect on the Risk of Disease
The analysis includes SNPs 60–64, which are missing indepen-
dently with the same probability.
Nicolae10 estimated the allele frequency for the untyped
SNP by a weighted sum of the haplotype frequencies of the
(M  1) genotyped SNPs, with the weights determined by
the haplotype frequencies of the M SNPs in the reference
panel, and he dubbed the corresponding association test
TUNA (testing untyped alleles). Zaitlen et al.11 proposed a class
of tests based on the weighted sum of haplotype frequencies,
which includes Nicolae’s test and the single-haplotype test of
de Bakker et al.9 as special cases, and they found the set of
weights used by Nicolae10 to be optimal. The variance estima-
tors provided by Zaitlen et al.11 are based on the multinomial
distribution of haplotypes and thus require the use of haplo-
type data rather than genotype data. According to the docu-
mentation for the TUNA software, there are numerical difﬁcul-
ties with the testing procedure originally suggested by
Nicolae.10 The TUNA software estimates the variance of the
test statistic by two methods: an asymptotic interpretation of
MD and bootstrap. There is no explanation of the ﬁrst method,
d the second method is computationally intensive. We propose
estimate the variance of the weighted sum of (estimated)
aplotype frequencies by using the information matrix for
e haplotype frequencies based on (unphased) genotype data.
his variance estimation is statistically valid and computationally
ﬁcient.
esults
imulation Studies
e used Monte Carlo simulation to evaluate the new and
isting methods. We simulated genotypes for various sets
f SNPs according to the haplotype distributions observed
the CEU sample of the HapMap project.1 We generated
e disease status from Model 1 with a potentially causal
P. For each scenario, we set the overall disease rate to ap-
roximately 5% and obtained 10,000 simulated data sets
ith 1,000 cases and 1,000 controls.
We ﬁrst studied the problem of genotyped SNPs with
issing data. We were particularly interested in SNPs
0–64 on chromosome 18 of the CEU sample in the
apMap genome-wide data. This set of SNPs was previ-
usly considered by Lin and Huang,8 who provided its
aplotype frequencies. The LD among these ﬁve SNPs is
ot particularly strong. We set SNP 60 to be causal with
additive effect. We let the genotypes of the ﬁve SNPs
e missing independently with the same probability and
erformed multi-SNP analysis by including all ﬁve SNPs
the logistic model. We compared the new method
the imputation method based on the output of fast-
HASE.4
Figures 1 and 2 display, respectively, the type I error of
e association tests at SNP 61, which is null, and the2008
power of the association tests at SNP 60, which is causal.
Clearly, the new method maintains its type I error around
the nominal signiﬁcance level. The imputation method
based on fastPHASE has inﬂated type I error, the inﬂation
worsening as more genotypes are missing and as the
odds ratio of the causal SNP increases. The new method
is more powerful than fastPHASE. The improvement of
the new method over the standard complete-case analysis
is substantial. The loss of power—caused by missing geno-
types—for the new method is rather moderate, even when
there is substantial missingness and the LD among the
SNPs is weak.
We extensively studied the problem of untyped SNPs.
We considered the two regions shown in Tables 1 and 2
of Nicolae,10 as well as various subsets of the ﬁrst 100
SNPs on chromosome 18 of the CEU sample in the Hap-
Map genome-wide data. For each region, we set a poten-
tially causal SNP to be untyped and performed single-
SNP analysis on that SNP. In addition to the case-control
sample, we generated a reference panel with 30 trios. All
the case-control subjects had missing values at the un-
typed SNPs, whereas the trios had known genotypes at all
SNPs.
We evaluated the newmethod as well as the two existing
approaches mentioned earlier: imputation of missing ge-
notypes and estimation of allele frequencies. For the impu-
tation approach, we used the EM algorithm to estimate
the haplotype frequencies of the M SNPs from the trio
data and then determined the probability distribution of
the untyped SNP. (Other imputationmethods are expected
to yield similar estimates when M is small.) We then used
the probability distribution in the corresponding associa-
tion test, as recommended by Marchini et al.5 For the
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lThe AmeFigure 2. Power of Association Tests on SNP 60, which Has
an Additive Effect on the Risk of Disease, at the 1% Nomi-
nal Significance Level
The analysis includes SNPs 60–64, which are missing indepen-
dently with the same probability. For complete-case analysis,
all subjects with missing data are removed. For full-data anal-
ysis, the missing genotypes are replaced by their true values.
allele-frequency estimation approach, we used the
method of Nicolae,10 together with our proposed vari-
ance estimator.
In all simulation studies, the new method estimated
the odds ratio with little bias (see Supplemental Data
available online). The variance estimator for the esti-
mated odds ratio accurately reﬂects the true variation.
The corresponding Wald test had proper type I error,
and the conﬁdence interval had correct coverage; see
Supplemental Data. The Nicolae method (with our var-
iance estimator) also had appropriate type I error. The
imputation method did not always preserve the type I
error. For Table 1 of Nicolae,10 the imputation method
had type I error of approximately 3% (under the addi-
tive model) at the targeted signiﬁcance level of 1%.
Figures 3 and 4 contrast the power curves of the three
ompeting methods for four regions on chromosome 18
f the HapMap CEU sample under the additive and
ecessive models, respectively. The new method is more
owerful than the two existing methods, especially when
s
2 is small. The power differences aremuchmore profound
nder the recessivemodels than under the additivemodels.
he imputation method tends to be more powerful than
icolae’s method.
heumatoid Arthritis Data
he North American Rheumatoid Arthritis Consortium
onducted a case-control study to identify genetic factors
hat predispose for rheumatoid arthritis (RA). RA is a com-
lex disease with a moderately strong genetic component.
he recurrence-risk ratio for siblings is estimated at around
in Caucasians. The prevalence in Caucasians is approxi-
ately 0.8%. Females tend to be at higher risk than males,
ith an approximately 3 to 1 preponderance. The mean
ge of disease onset is in the ﬁfth decade, with considerable
ariability.
A total of 460 cases were selected from throughout the
nited States. Conﬁrmation of RA diagnosis was obtained
rom patients’ rheumatologists. Radiographs of the hands
nd wrists were also obtained to document the presence
nd extent of joint involvement. A total of 460 unrelated
ontrols from Long Island, New York City were fre-
uency-matched to the cases by age and sex. All study sub-
ects are non-Ashkenazi Caucasians.
A dense panel of 2,297 SNPs were genotyped by Illumina
or an approximately 10 Mb region of chromosome 18q
hat showed evidence for linkage in the U.S. and French
inkage scans. The SNPs were a custom set selected fromrican Journal of Human Genetics 82, 444–452, February 2008 447
dbSNP ‘‘double hit’’ SNPs on the basis of their distribution
and favorable assay design characteristics. The 2,297 SNPs
represent the SNPs successfully typed with minor allele fre-
quency greater than 5% out of the 3,072 SNPs attempted.
We applied the new method to this study, with the Hap-
Map CEU sample as the reference panel. As an illustration,
we show inFigure 5 the results in a315kb regioncontaining
the ferrochelatase gene (FECH [MIM 177000]). This region
covers 100 SNPs genotyped in the RA study and 210
untyped HapMap SNPs with minor allele frequency (MAF)
> 5%. For each untyped SNP, we found a set of four geno-
typed SNPs within 30 kb that yields the largest Rs
2. Only
four untyped SNPs had Rs
2 < 0.25, all of which had MAF
< 7%. There were 94% of the SNPs with Rs
2 > 0.5, 78%
with Rs
2 > 0.8, 67% with Rs
2 > 0.9, and 50% with Rs
2 ¼ 1.
The ﬁgure displays the results for both the genotyped and
untyped SNPs. The inclusion of the results at the untyped
SNPs enables us to have a much more detailed view of the
region and provides stronger evidence of association than
those of the genotyped SNPs alone. The strength of associ-
ation signal from the untyped SNPs is similar to that of
the genotyped SNPs at the beginning and the end of the re-
gion. In the middle of the region, most of the signal comes
from the untyped SNPs. Among the ten most signiﬁcant
Figure 3. Power of Association Tests
for Untyped SNPs at the 1% Nominal Sig-
nificance Level under Additive Models
for Four Regions of Five SNPs on Chro-
mosome 18 of the HapMap CEU Sample
(A) SNP 21 in the region of SNPs 20–24
with MAF of 0.40 and Rs
2 of 0.24.
(B) SNP 22 in the region of SNPs 20–24
with MAF of 0.25 and Rs
2 of 0.42.
(C) SNP 26 in the region of SNPs 24–28
with MAF of 0.25 and Rs
2 of 0.85.
(D) SNP 65 in the region of SNPs 63–67
with MAF of 0.37 and Rs
2 of 0.62.
untyped SNPs, two had estimated
odds ratios of 1.65 and 1.54, and the
rest had estimatedodds ratios of about
1.4. The ten most signiﬁcant geno-
typed SNPs all had estimated odds
ratios of about 1.4.
Discussion
We have presented a simple and co-
herent framework for dealing with
missing genotypes. Our approach
fully accounts for the uncertainty in
predicting the unknown variants, so
that the estimated odds ratios are
attached with appropriate standard-
error estimates and the corresponding
association tests have correct type I
error, even if the unknown variants are predicted with poor
accuracy. For genotyped SNPs with missing values, our ap-
proach is likely to bemore useful when genotypes are miss-
ing by design rather than by chance. With the continuing
improvements in genotyping technologies, missing data
for genotyped SNPs have been reduced rapidly; however,
it may not be economically feasible to genotype all study
subjects on a high-density platform or to completely se-
quence a large number of individuals.
For untyped SNPs, it is necessary to use external data to
determine the joint distribution of the untyped and typed
variants. For genotyped SNPs with partial missing data, it is
not necessary to use external data, so greater robustness
can be achieved by employing the likelihood based solely
on the study data. For untyped SNPs, Nicolae’s method
tends to be less powerful than the newmethod and the im-
putation method. However, Nicolae’s method is expected
to be more robust to the choice of the reference panel be-
cause the genotypes of the reference panel enter into the
test statistic only as weights.
The ﬁrst step of our method is very similar to that of
Nicolae’s in that both methods identify a small number
of genotyped SNPs that provides the best prediction for
the untyped SNP. By contrast, Marchini et al.5 used448 The American Journal of Human Genetics 82, 444–452, February 2008
information from all markers in LD with the untyped SNP
in a way that decreases with genetic distance from the un-
typed SNP. The latter approach avoids the decision to
Figure 4. Power of Association Tests
for Untyped SNPs at the 1% Nominal Sig-
nificance Level under Recessive Models
for Four Regions of Five SNPs on Chro-
mosome 18 of the HapMap CEU Sample
(A) SNP 21 in the region of SNPs 20–24
with MAF of 0.40 and Rs
2 of 0.24.
(B) SNP 22 in the region of SNPs 20–24
with MAF of 0.25 and Rs
2 of 0.42.
(C) SNP 26 in the region of SNPs 24–28
with MAF of 0.25 and Rs
2 of 0.85.
(D) SNP 65 in the region of SNPs 63–67
with MAF of 0.37 and Rs
2 of 0.62.
choose a set of markers, but requires
an approximate population-genetics
model. Although our approach uses
a small set of markers to predict the
unknown variants, that set is chosen
to provide the best prediction among
all relevant sets of markers in LD with
the untyped SNP. This strategy yields
a very accurate prediction for most
HapMap SNPs, as demonstrated in
the RA example.
Although the numerical results re-
ported in this article were focused
onmain genetic effects, our approach
can be used to detect gene-gene and
gene-environment interactions. The
imputation approach can also be
used to test interactions by using the
Figure 5. Results of Association Tests
for Additive Effects in the Region of
the FECH Gene from the RA Data
log10(p values) for the genotyped and
untyped SNPs are shown in blue circle
and red diamonds, respectively.
most likely genotype or the expected genotype counts,
but it would be difﬁcult to use the probability distribution
of the genotype.The American Journal of Human Genetics 82, 444–452, February 2008 449
A unique feature of our approach is that it provides
valid estimates of odds ratios for genetic effects as well
as gene-environment interactions. Although the ﬁrst
scan of the genome is typically done by association tests,
most genome-wide association studies have reported
odds-ratio estimates. Our method offers such estimates,
together with appropriate conﬁdence intervals, for un-
typed SNPs.
Another advantage of our approach is that it is computa-
tionally very fast. It takes less than 1 s on an IBM HS21
machine to perform the association analysis at an untyped
SNP for a study with 2,000 individuals. Thus, the analysis
of 3 million untyped SNPs can be completed overnight
with a cluster of 50 machines. The software—called
SNPMStat—implementing the new method is available at
the Lin lab website.
Our simulation studies were concerned with a small
number of markers and did not incorporate the hidden
Markov model of Marchini et al.5 It would be highly valu-
able to compare the performance of competingmethods in
various genome-wide association studies as well as in large-
scale simulation studies mimicking real data. Indeed, this
task is currently taken on by the imputation subgroup of
the GAIN Collaborative Research Group.15
Like the existing methods, our method requires Hardy-
Weinberg equilibrium. This assumption may be violated
when there is population substructure. We can relax this
assumption by incorporating an inbreeding coefﬁcient
into the Hardy-Weinberg proportions and modifying the
numerical algorithms accordingly.14 If the study involves
different race groups, then the likelihoods LC(q) should
be constructed separately for each race group and then
multiplied together.
It is of interest to assess genome-wide statistical signiﬁ-
cance. Because of the strong LD among densely distributed
polymorphisms, the commonlyusedBonferroni correction
is punitively conservative, especially when all HapMap
SNPs are tested. The permutation test is not computation-
ally feasible and may be inappropriate for detecting gene-
environment interactions. We are currently exploring the
use of theMonte Carlo approach of Lin,16 which is efﬁcient
and versatile.
There has been a considerable debate about whether
one should use SNP-based or haplotype-based analysis.
The relative power depends on several factors.9,10,17–19
This article assumes that SNP-based analysis is of primary
interest. So far, the ﬁrst scan of the genome has always
been performed with single-SNP tests. Our method uses
the haplotype distribution to infer missing genotypes
and can be uniﬁed with our earlier work on the analysis
of haplotype-disease association.14
This article is focused on case-control studies with refer-
ence panels consisting of trios. We are currently extending
our approach to other study designs and phenotypes, as
well as other types of reference panels. Indeed, our software
already allows both trios and unrelated individuals as refer-
ence panels.450 The American Journal of Human Genetics 82, 444–452, FebruaAppendix A
Maximization of Case-Control Likelihood
We show how to maximize the likelihood of the case-
control study given in Equation 4. The maximization of
the likelihood in Equation 2 is similar but simpler. In the
absence of environmental factors, the maximization of the
likelihood in Equation 4 yields the same estimators of
bandpas thatofEquation2.Thus, Equation2canbe treated
as a special case of Equation 4 for numerical purposes.
We use the EM algorithm20,21 to obtain initial estimates
of haplotype frequencies based on the control sample. To
avoid numerical instabilities in the maximization of the
likelihood in Equation 4, we exclude those haplotypes
whose estimated frequencies are 0 or very close to 0, i.e.,
< max(2/n, 0.001). We redeﬁne K as the total number of
haplotypes that are retained.
To accommodate the constraints
PK
k¼1 pk ¼ 1 and pk R
0 (k ¼ 1,., K), we deﬁne pk* ¼ pk/pK and nk ¼ log pk*. Write
n ¼ (n1,., nK1)T, q ¼ (m, bT, nT)T, and
Wðhk,hl,y,xÞ ¼
2
6666664
y
yZðhk,hl,xÞ
Iðhk ¼ h1Þ þ Iðhl ¼ h1Þ
Iðhk ¼ h2Þ þ Iðhl ¼ h2Þ
«
Iðhk ¼ hK1Þ þ Iðhl ¼ hK1Þ
3
7777775
:
Then Equation 4 can be written as
LSðqÞ ¼
Yn
i¼1
P
ðhk ,hlÞGi e
qTWðhk,hl ,Yi ,XiÞP
k,l,y e
qTWðhk,hl ,y,XiÞ
:
The corresponding score function and information matrix
are
USðqÞ ¼
Xn
i¼1
8><
>:
P
ðhk ,hlÞGi e
qTWðhk,hl ,Yi ,XiÞWðhk,hl,Yi,XiÞP
ðhk,hlÞGi e
qTWðhk ,hl ,Yi,XiÞ

P
k,l,y e
qTWðhk,hl ,y,XiÞWðhk,hl,y,XiÞP
k,l,y e
qTWðhk ,hl,y,XiÞ
9>=
>;,
and
SSðqÞ ¼
Pn
i¼1
2
4
P
k,l,y
eq
TWðhk ,hl ,y,XiÞWðhk,hl ,y,XiÞ52P
k,l,y
eq
TWðhk ,hl ,y,XiÞ

8<
:
P
k,l,y
eq
TWðhk ,hl ,y,XiÞWðhk,hl,y,XiÞP
k,l,y
eq
TWðhk ,hl ,y,XiÞ
9=
;
52
3
75
Pni¼1
2
4
P
ðhk ,hlÞGi e
qTWðhk ,hl ,Yi ,XiÞWðhk ,hl,Yi ,XiÞ52P
ðhk ,hlÞGi e
qTWðhk ,hl ,Yi ,XiÞ

8<
:
P
ðhk ,hlÞGi
eq
TWðhk ,hl ,Yi ,XiÞWðhk ,hl,Yi,XiÞP
ðhk ,hlÞGi
eq
TWðhk ,hl ,Yi ,XiÞ
9=
;
52
3
75,ry 2008
respectively, where a52 ¼ aaT. To obtain the MLE q^, we
solve the equation US(q) ¼ 0 by the Newton-Raphson
algorithm. The initial values of m and b are set to 0, and
the initial value of n is based on the estimated haplotype
frequencies from the control sample.
By deﬁnition,
p1 ¼ e
n1
1þPK1k¼1 enk ,/,pK1 ¼
enK1
1þPK1k¼1 enk ,
pK ¼ 1
1þPK1k¼1 enk :
We use the above transformations to obtain the MLE
ðp^1,.,p^kÞ from ðn^1,.,n^K1Þ. Let J be the Jacobian matrix
of (m, bT, p1, ., pK)
T with respect to (m, bT, n1, ., nK1)
T.
That is, the ﬁrst row of J is the derivative of m with respect
to (m, bT, n1,., nK1)
T, which equals (1, 0,., 0); the other
rows are calculated similarly. Then the standard-error
estimates for ðm^,b^T,p^1,.,p^KÞT are the square roots of the
diagonal elements in the matrix JS1S ðq^ÞJT.
Appendix B
Maximization of Combined Likelihood
We obtain initial estimates of haplotype frequencies for
theM SNPs by applying the EM algorithm to the likelihood
for the reference-trio data given in Equation 3. We exclude
the haplotypes with estimated frequencies < max(2/n,
0.001) and redeﬁne K as the number of retained haplo-
types. As in Appendix A, we reparametrize p as n and rede-
ﬁne q ¼ (m, bT, nT)T. Then Equation 3 becomes
LRðnÞ ¼
2
4Y~n
j¼1
X
ðhk,hl ,hk0 ,hl0 ÞGj
en
TQ
klk
0
l
0
3
51þXK1
k¼1
enk
4~n
,
where
Qklk0 l0 ¼
2
4 Iðhk ¼ h1Þ þ Iðhl ¼ h1Þ þ I

hk0 ¼ h1
þ Ihl0 ¼ h1
«
Iðhk ¼ hK1Þþ Iðhl ¼ hK1Þþ I

hk0 ¼ hK1
þ Ihl0 ¼ hK1
3
5:
The corresponding score function and information
matrix are
URðnÞ ¼
X~n
j¼1
P
ðhk ,hl ,hk0 ,hl0 ÞGj e
nTQ
klk
0
l
0 Qklk0 l0P
ðhk ,hl ,hk0 ,hl0 ÞGj e
nTQ
klk
0
l
0
 4~nEðnÞ
1þPK1k¼1 enk ,
and
SRðnÞ ¼ 4~n
8><
>:
DðnÞ
1þPK1k¼1 enk 
EðnÞ52
ð1þPK1k¼1 enk Þ2
9>>=
>>;
P~nj¼1
2
664
P
ðhk ,hl ,hk0 ,hl0 ÞGj e
nTQ
klk
0
l
0
Q52
klk0 l0P
ðhk ,hl ,hk0 ,hl0 ÞGj e
nTQ
klk
0
l
0 
8><
>:
P
ðhk ,hl ,hk0 ,hl0 ÞGj
e
nTQ
klk
0
l
0
Q
klk
0
l
0P
ðhk ,hl ,hk0 ,hl0 ÞGj
e
nTQ
klk
0
l
0
9>=
>;
523
775,
respectively, whereThe AmEðnÞ ¼
2
664
en1
en2
«
enK1
3
775,DðnÞ ¼
2
664
en1 0 / 0
0 en2 / 0
« « « «
0 0 / enK1
3
775
The score function and information matrix associated
with the combined likelihood LC(q) are
UCðqÞ ¼ USðqÞ þ

0
URðnÞ

and
SCðqÞ ¼ SSðqÞ þ

0 0
0 SRðnÞ

,
respectively. To obtain the MLE q^, we solve the equation
UC(q) ¼ 0 by the Newton-Raphson method. The initial
values of m and b are set to 0, and the initial value of n is
based on the estimated haplotype frequencies of the refer-
ence database. We then transform n to p and obtain the
standard-error estimates for b^ and p^ in the same manner
as in Appendix A.
Supplemental Data
One table is available at http://www.ajhg.org/.
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The URLs for data presented herein are as follows:
The North American Rheumatoid Arthritis Consortium, http://
www.naracdata.org
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
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SNPMStat (for C code for implementing the new method), http://
www.bios.unc.edu/~lin/software/SNPMStat
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